A Nanoparticle Therapy to Treat Lung Cancer and Associated Muscle Wasting at the Same Time

New technique can simultaneously treat lung cancer and muscle-wasting condition

Researchers at Oregon State University have developed a technique for simultaneously treating lung cancer and a serious muscle-wasting condition that often accompanies it.

A nanoparticle therapy to treat lung cancer and associated muscle wasting at the same time

Researchers at Oregon State University have developed a technique for simultaneously treating lung cancer and a serious muscle-wasting condition that often accompanies it. The study, published in the Journal of Controlled Release, involves lipid nanoparticles delivering therapeutic genetic material to lung tumors.

OSU Researchers find way to treat lung cancer and associated muscle wasting at the same time

Free news from Oregon State University.

Scientists Discover Dual Treatment for Lung Cancer and Muscle Wasting

Researchers at Oregon State University have pioneered a transformative approach for simultaneously targeting lung cancer and the debilitating muscle-wasting syndrome known as cachexia—a condition that plagues many lung cancer patients. Their groundbreaking work employs lipid nanoparticles (LNPs) as a delivery vehicle for messenger RNA (mRNA) therapeutics, addressing critical challenges in precision drug delivery for aggressive tumors deep within…